AmerisourceBergen Corporation – NYSE:ABC
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 16 hours
AmerisourceBergen stock price monthly change
-2.44%
month
AmerisourceBergen stock price quarterly change
+6.87%
quarter
AmerisourceBergen stock price yearly change
+22.03%
year
AmerisourceBergen key metrics
Market Cap | 36.14B |
Enterprise value | 47.57B |
P/E | 23.96 |
EV/Sales | 0.17 |
EV/EBITDA | 11.82 |
Price/Sales | 0.16 |
Price/Book | 36.17 |
PEG ratio | 5.89 |
EPS | 8.37 |
Revenue | 267.74B |
EBITDA | 3.98B |
Income | 1.68B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0.67% |
Oper. margin | 1% |
Gross margin | 3.23% |
EBIT margin | 1% |
EBITDA margin | 1.49% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAmerisourceBergen stock price history
AmerisourceBergen stock forecast
AmerisourceBergen financial statements
| Mar 2023 | 63.45B | 435.40M | 0.69% |
|---|---|---|---|
| Jun 2023 | 66.94B | 479.58M | 0.72% |
| Sep 2023 | 68.92B | 350.56M | 0.51% |
| Mar 2024 | 68.41B | 420.77M | 0.62% |
0.90%
Yield TTM
| Payout ratio | 22.13% |
|---|
| 2019 | 1.96% |
|---|---|
| 2020 | 1.73% |
| 2021 | 1.49% |
| 2022 | 1.39% |
| 2023 |
| Mar 2023 | 58766183000 | 58.25B | 99.13% |
|---|---|---|---|
| Jun 2023 | 61177196000 | 60.25B | 98.49% |
| Sep 2023 | 62558746000 | 61.89B | 98.93% |
| Mar 2024 | 63868046000 | 62.64B | 98.08% |
| Mar 2023 | 629.50M | -88.73M | -769.44M |
|---|---|---|---|
| Jun 2023 | 744.93M | -819.12M | -81.87M |
| Sep 2023 | 1.82B | -183.44M | -407.01M |
| Mar 2024 | -878.44M | -166.48M | 323.17M |
AmerisourceBergen alternative data
| Aug 2023 | 39,000 |
|---|---|
| Sep 2023 | 46,000 |
| Oct 2023 | 46,000 |
| Nov 2023 | 46,000 |
| Dec 2023 | 46,000 |
| Jan 2024 | 46,000 |
| Feb 2024 | 46,000 |
| Mar 2024 | 46,000 |
| Apr 2024 | 46,000 |
| May 2024 | 46,000 |
| Jun 2024 | 46,000 |
| Jul 2024 | 46,000 |
AmerisourceBergen other data
64.28%
-0.32%
of ABC is owned by hedge funds
857
+7
135.72M
+1.06M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Oct 2022 | 0 | 11480 |
| Nov 2022 | 0 | 13255955 |
| Dec 2022 | 0 | 94113 |
| Jan 2023 | 0 | 10499 |
| Feb 2023 | 0 | 16210 |
| Mar 2023 | 0 | 12423 |
| Apr 2023 | 0 | 10499 |
| May 2023 | 0 | 310791 |
| Jun 2023 | 0 | 314025 |
| Jul 2023 | 0 | 10499 |
| Aug 2023 | 0 | 1331357 |
| Sep 2023 | 0 | 2733 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | DONATO LESLIE E officer: EVP & Chief Strategy O.. | Common Stock | 1,845 | $86.09 | $158,836 | ||
Option | DONATO LESLIE E officer: EVP & Chief Strategy O.. | Non-qualified Stock Option (Right to Buy) | 1,845 | $86.09 | $158,836 | ||
Sale | DONATO LESLIE E officer: EVP & Chief Strategy O.. | Common Stock | 1,845 | $175 | $322,875 | ||
Option | DONATO LESLIE E officer: EVP & Chief Strategy O.. | Common Stock | 4,929 | $86.09 | $424,338 | ||
Option | DONATO LESLIE E officer: EVP & Chief Strategy O.. | Non-qualified Stock Option (Right to Buy) | 4,929 | $86.09 | $424,338 | ||
Sale | DONATO LESLIE E officer: EVP & Chief Strategy O.. | Common Stock | 888 | $175 | $155,400 | ||
Option | COLLIS STEVEN H director, officer.. | Common Stock | 10,499 | $77.53 | $813,987 | ||
Sale | COLLIS STEVEN H director, officer.. | Common Stock | 10,499 | $186.19 | $1,954,809 | ||
Option | COLLIS STEVEN H director, officer.. | Non-qualified Stock Option (Right to Buy) | 10,499 | $77.53 | $813,987 | ||
Sale | WALGREENS BOOTS ALLIANCE, INC. 10 percent owner | Common Stock | 1,320,858 | $189.27 | $250,000,115 |
| Quarter | Transcript |
|---|---|
| Q3 2023 2 Aug 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 2 May 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 1 Feb 2023 | Q1 2023 Earnings Call Transcript |
| Q3 2022 3 Aug 2022 | Q3 2022 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Steven H. Collis (1961) Chairman, Pres & Chief Executive Officer | $4,550,000 |
Dr. Robert P. Mauch PharmD, Ph.D. (1967) Executive Vice President & Group Pres | $1,810,000 |
| Mr. James F. Cleary Jr. (1963) Executive Vice President & Chief Financial Officer | $1,780,000 |
| Mr. John G. Chou (1956) Executive Vice President and Special Advisor to the Chairman & Chief Executive Officer | $1,750,000 |
| Ms. Gina K. Clark (1957) Executive Vice President and Chief Communications & Admin. Officer | $1,460,000 |
AmerisourceBergen: Focused On Megatrend-Driven Margin Expansion
AmerisourceBergen: A Strong Addition To Any Portfolio
AmerisourceBergen Screams Quality At 15x Earnings, 60% ROIC
Walgreens: Enough Is Enough?
McKesson Corporation: Still Trading Below Intrinsic Value
The Importance Of Government Contracting For AmerisourceBergen
AmerisourceBergen Corporation: Looking Healthier
Back To The Future With AmerisourceBergen Corporation
Why AmerisourceBergen Is The Best-In-Class Pharmaceuticals Distributor
-
When is AmerisourceBergen's next earnings date?
Unfortunately, AmerisourceBergen's (ABC) next earnings date is currently unknown.
-
Does AmerisourceBergen pay dividends?
Yes, AmerisourceBergen pays dividends and its trailing 12-month yield is 0.91% with 22% payout ratio. The last AmerisourceBergen stock dividend of $0.46 was paid on 28 Feb 2022.
-
How much money does AmerisourceBergen make?
AmerisourceBergen has a market capitalization of 36.14B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.89% to 262.17B US dollars.
-
What is AmerisourceBergen's stock symbol?
AmerisourceBergen Corporation is traded on the NYSE under the ticker symbol "ABC".
-
What is AmerisourceBergen's primary industry?
Company operates in the Healthcare sector and Medical - Distribution industry.
-
How do i buy shares of AmerisourceBergen?
Shares of AmerisourceBergen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are AmerisourceBergen's key executives?
AmerisourceBergen's management team includes the following people:
- Mr. Steven H. Collis Chairman, Pres & Chief Executive Officer(age: 64, pay: $4,550,000)
- Dr. Robert P. Mauch PharmD, Ph.D. Executive Vice President & Group Pres(age: 58, pay: $1,810,000)
- Mr. James F. Cleary Jr. Executive Vice President & Chief Financial Officer(age: 62, pay: $1,780,000)
- Mr. John G. Chou Executive Vice President and Special Advisor to the Chairman & Chief Executive Officer(age: 69, pay: $1,750,000)
- Ms. Gina K. Clark Executive Vice President and Chief Communications & Admin. Officer(age: 68, pay: $1,460,000)
-
How many employees does AmerisourceBergen have?
As Jul 2024, AmerisourceBergen employs 46,000 workers.
-
When AmerisourceBergen went public?
AmerisourceBergen Corporation is publicly traded company for more then 30 years since IPO on 4 Apr 1995.
-
What is AmerisourceBergen's official website?
The official website for AmerisourceBergen is amerisourcebergen.com.
-
Where are AmerisourceBergen's headquarters?
AmerisourceBergen is headquartered at 1 West First Avenue, Conshohocken, PA.
-
How can i contact AmerisourceBergen?
AmerisourceBergen's mailing address is 1 West First Avenue, Conshohocken, PA and company can be reached via phone at +61 7277000.
AmerisourceBergen company profile:
AmerisourceBergen Corporation
amerisourcebergen.comExchange:
NYSE
Full time employees:
46,000
Industry:
Medical - Distribution
Sector:
Healthcare
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
1 West First Avenue
Conshohocken, PA 19428-1800
Conshohocken, PA 19428-1800
CIK: 0001140859
ISIN: US03073E1055
CUSIP: 03073E105
